ATE361365T1 - Streptococcus pneumoniae proteine und nukleinsäuren - Google Patents

Streptococcus pneumoniae proteine und nukleinsäuren

Info

Publication number
ATE361365T1
ATE361365T1 AT99934989T AT99934989T ATE361365T1 AT E361365 T1 ATE361365 T1 AT E361365T1 AT 99934989 T AT99934989 T AT 99934989T AT 99934989 T AT99934989 T AT 99934989T AT E361365 T1 ATE361365 T1 AT E361365T1
Authority
AT
Austria
Prior art keywords
streptococcus pneumoniae
nucleic acids
pneumoniae proteins
proteins
vaccines
Prior art date
Application number
AT99934989T
Other languages
English (en)
Inventor
Christophe Francois Gu Gilbert
Philip Michael Hansbro
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816337.1A external-priority patent/GB9816337D0/en
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Application granted granted Critical
Publication of ATE361365T1 publication Critical patent/ATE361365T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99934989T 1998-07-27 1999-07-27 Streptococcus pneumoniae proteine und nukleinsäuren ATE361365T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9816337.1A GB9816337D0 (en) 1998-07-27 1998-07-27 Proteins
US12516499P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
ATE361365T1 true ATE361365T1 (de) 2007-05-15

Family

ID=26314125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99934989T ATE361365T1 (de) 1998-07-27 1999-07-27 Streptococcus pneumoniae proteine und nukleinsäuren

Country Status (5)

Country Link
EP (2) EP1100921B1 (de)
JP (6) JP2002531055A (de)
AT (1) ATE361365T1 (de)
DE (1) DE69935986D1 (de)
WO (1) WO2000006737A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
DE69940439D1 (de) * 1998-12-21 2009-04-02 Medimmune Inc Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
EP1950302B1 (de) 1998-12-23 2012-12-05 ID Biomedical Corporation of Quebec Streptokokken-Antigene
KR100802198B1 (ko) * 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
EP1075841A1 (de) * 1999-08-13 2001-02-14 Erasmus Universiteit Rotterdam Pneumokokkus Impfstoffe
WO2001098334A2 (en) * 2000-06-20 2001-12-27 Shire Biochem Inc. Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
US7892552B2 (en) 2001-08-08 2011-02-22 University Of Utah Research Foundation Group B Streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
AU2001281168A1 (en) 2000-08-08 2002-02-18 St. Jude Children's Research Hospital Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
ATE439372T1 (de) 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
US7595057B2 (en) 2000-12-21 2009-09-29 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
EP1456231A2 (de) 2001-12-20 2004-09-15 Shire Biochem Inc. Streptococcus antigene
CN100443116C (zh) * 2002-11-07 2008-12-17 新纳几美国公司 治疗或预防肺炎球菌感染的组合物及其用途
EP2333114A1 (de) * 2003-04-15 2011-06-15 Intercell AG S. pneumoniae Antigene
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
CN1909921B (zh) * 2003-11-10 2012-09-26 Uab研究基金会 减少细菌携带和中枢神经系统侵害的组合物及其使用方法
EP2059807B1 (de) 2006-08-17 2013-02-20 The UAB Research Foundation Diagnose von pneumokokken-lungenentzündung
US8722055B2 (en) 2006-09-27 2014-05-13 St. Jude Children's Research Hospital Synthetic Streptococcus pneumoniae vaccine
EP2251035A3 (de) * 2007-04-12 2011-03-16 Stichting Katholieke Universiteit, more particularly the Radboud University Nijmegen Medical Centre Neue Virulenzfaktoren von Pneumokokken
MX2009012676A (es) 2007-05-23 2010-02-12 Uab Research Foundation Neuraminidasa neumococica no toxica y sus usos.
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
ES2546213T3 (es) 2008-03-03 2015-09-21 Novartis Ag Compuestos y composiciones como moduladores de la actividad de TLR
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
AU2010290896B2 (en) 2009-09-02 2014-07-03 Glaxosmithkline Biologicals S.A. Immunogenic compositions including TLR activity modulators
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
EP2538971B1 (de) 2010-02-23 2015-10-28 Stichting Katholieke Universiteit Kombinationsimpfstoff für streptococcus
EP3165531B1 (de) 2010-03-12 2020-11-25 Children's Medical Center Corporation Immunogene zusammensetzung, vakzin und deren verwendung
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
CN104519910B (zh) 2012-03-07 2017-05-03 诺华股份有限公司 肺炎链球菌抗原的含佐剂制剂
TR201807340T4 (tr) 2013-02-01 2018-06-21 Glaxosmithkline Biologicals Sa Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
CA2900008C (en) 2013-02-07 2025-10-07 Children's Medical Center Corporation PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
GB201509782D0 (en) * 2015-06-05 2015-07-22 Isis Innovation Methods and products for fusion protein synthesis
PL3752182T3 (pl) 2018-02-12 2024-11-25 Inimmune Corporation Ligandy receptorów toll-podobnych
IL281204B2 (en) 2018-09-12 2025-07-01 Affinivax Inc Multivalent pneumococcal vaccines
CA3198876A1 (en) 2020-11-04 2022-05-12 Eligo Bioscience Cutibacterium acnes recombinant phages, method of production and uses thereof
AU2022342080A1 (en) 2021-09-09 2024-03-28 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
JP2000514308A (ja) * 1996-08-16 2000-10-31 スミスクライン・ビーチャム・コーポレイション 新規原核生物ポリヌクレオチド、ポリペプチドおよびそれらの使用
CA2271720A1 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
EP0885966A3 (de) * 1997-06-20 1999-12-29 Smithkline Beecham Corporation Neue Verbindungen
EP0891984A3 (de) * 1997-06-20 2000-01-19 Smithkline Beecham Corporation Nukleinsäure kodierend für streptococcus pneumoniae response-regulator
EP1790730A3 (de) * 1998-07-27 2007-09-12 Sanofi Pasteur Limited Pneumokokkenproteine und Nukleinsäuremoleküle

Also Published As

Publication number Publication date
JP2008263969A (ja) 2008-11-06
WO2000006737A8 (en) 2000-11-09
WO2000006737A3 (en) 2000-06-29
JP2008263968A (ja) 2008-11-06
DE69935986D1 (de) 2007-06-14
EP1100921B1 (de) 2007-05-02
WO2000006737A2 (en) 2000-02-10
JP2008263970A (ja) 2008-11-06
EP2053126A1 (de) 2009-04-29
JP2002531055A (ja) 2002-09-24
JP2009148283A (ja) 2009-07-09
JP2008263966A (ja) 2008-11-06
EP1100921A2 (de) 2001-05-23

Similar Documents

Publication Publication Date Title
DE69935986D1 (de) Streptococcus pneumoniae proteine und nukleinsäuren
WO2000006738A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
WO2000039299A3 (en) Streptococcus antigens
WO2000006736A3 (en) Nucleic acids and proteins from group b streptococcus
ATE479756T1 (de) Streptococcus pneumoniae-antigene und impfstoffe
DK1093517T3 (da) Neisseria-meningitidis-antigener og præparater
DE69731285D1 (de) Langwellig fluorezierende proteine
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
WO1999042588A3 (en) Group b streptococcus antigens
EA200201280A1 (ru) Стрептококковые антигены
WO2001032882A3 (en) Nucleic acids and proteins from group b streptococcus
WO2002079241A3 (en) Secreted streptococcus pneumoniae proteins
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
ATE350055T1 (de) Hämophilus influenzae adhärenz und penatrationsproteine
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
ATE439441T1 (de) Veränderte, fluoreszierende proteine
ATE134219T1 (de) Menschliches mk gen und protein-sequenz
WO2003016551A3 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
DE69728897D1 (de) Saeugetierchemokine
ATE435277T1 (de) 18477, eine menschliche proteinkinase und deren verwendung
EP1790730A3 (de) Pneumokokkenproteine und Nukleinsäuremoleküle
DE69935323D1 (de) Moraxella catharralis proteine
DE60037413D1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
DK1241179T3 (da) Humant protein med in vitro antiproliferativ aktivitet.
EP1624064A3 (de) Nukleinsäuren und entsprechende Proteine aus streptococcus pneumoniae

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties